This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: CVS Health (CVS)
by Derek Lewis
Guidance cuts stemming from weak quarterly results have caused shares to travel a rocky road in 2024.
Company News for Nov 19, 2024
by Zacks Equity Research
Companies In The News Are: TWST, CVS, OKLO, HSIC.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Estimates for CVS Southbound After Rocky Q3: How to Play the Stock
by Urmimala Biswas
CVS Health expects the elevated levels of utilization to continue to put pressure on its 2024 performance and as a result could not provide an outlook for 2024.
CVS Health Q3 Earnings & Revenues Beat, Stock Rises in Premarket
by Zacks Equity Research
CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.
CVS Health (CVS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVS Health (CVS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 1.87% and 2.75%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Herbalife Ltd (HLF) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Herbalife Ltd (HLF) delivered earnings and revenue surprises of 200% and 0.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
CVS Health (CVS) closed at $56.25 in the latest trading session, marking a -1.94% move from the prior day.
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock
by Urmimala Biswas
CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.
CVS Health (CVS) Stock Moves -0.12%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, CVS Health (CVS) stood at $56.78, denoting a -0.12% change from the preceding trading day.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WBA Stock Up 16% on New Restructuring Strategy: How to Play the Stock
by Urmimala Biswas
Walgreens Boots is currently going all out to reform its pharmacy model by aggressively liquidating its unprofitable stores and businesses.
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Assessing WBA Before Q4 Earnings: How Should You Play the Stock?
by Moumi Mondal
A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.
Why the Market Dipped But CVS Health (CVS) Gained Today
by Zacks Equity Research
CVS Health (CVS) reachead $62.92 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.
CVS Stock Hits 50-Day SMA on Split Rumors: How Should You Play?
by Urmimala Biswas
The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.